Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Michael Bristow to Heart Transplantation

This is a "connection" page, showing publications Michael Bristow has written about Heart Transplantation.

 
Connection Strength
  
 
 
1.920
  
  1. Shah P, Bristow MR, Port JD. MicroRNAs in Heart Failure, Cardiac Transplantation, and Myocardial Recovery: Biomarkers with Therapeutic Potential. Curr Heart Fail Rep. 2017 12; 14(6):454-464.
    View in: PubMed
    Score: 0.093
  2. Jaggers J, Fullerton DA, Campbell DN, Andrea B, Jones SD, Brown JM, Wolfel EE, Lindenfeld J, Grover FL, Bristow MR. Cardiac allograft failure: successful use of biventricular assist device. Ann Thorac Surg. 1995 Nov; 60(5):1409-11.
    View in: PubMed
    Score: 0.080
  3. Bristow MR. Use of oral enoximone in pharmacologic bridging to cardiac transplantation. Z Kardiol. 1994; 83 Suppl 2:15-9.
    View in: PubMed
    Score: 0.071
  4. Olsen SL, Renlund DG, O'Connell JB, Taylor DO, Lassetter JE, Eastburn TE, Hammond EH, Bristow MR. Prevention of Pneumocystis carinii pneumonia in cardiac transplant recipients by trimethoprim sulfamethoxazole. Transplantation. 1993 Aug; 56(2):359-62.
    View in: PubMed
    Score: 0.069
  5. O'Connell JB, Gilbert EM, Renlund DG, Bristow MR. Enoximone as a bridge to heart transplantation: the Utah experience. J Heart Lung Transplant. 1991 May-Jun; 10(3):477-81.
    View in: PubMed
    Score: 0.059
  6. O'Connell JB, Renlund DG, Hammond EH, Wittwer CT, Yowell RL, DeWitt CW, Jones KW, Gay WA, Menlove RL, Bristow MR. Sensitization to OKT3 monoclonal antibody in heart transplantation: correlation with early allograft loss. J Heart Lung Transplant. 1991 Mar-Apr; 10(2):217-21; discussion 221-2.
    View in: PubMed
    Score: 0.058
  7. Bristow MR. The surgically denervated, transplanted human heart. Circulation. 1990 Aug; 82(2):658-60.
    View in: PubMed
    Score: 0.056
  8. Renlund DG, O'Connell JB, Bristow MR. Strategies of immunosuppression in cardiac transplantation. Semin Thorac Cardiovasc Surg. 1990 Apr; 2(2):181-8.
    View in: PubMed
    Score: 0.054
  9. Woodley SL, Renlund DG, O'Connell JB, Bristow MR. Immunosuppression following cardiac transplantation. Cardiol Clin. 1990 Feb; 8(1):83-96.
    View in: PubMed
    Score: 0.054
  10. Hegewald MG, O'Connell JB, Renlund DG, Lee HR, Burton NA, Karwande SV, Jones KW, Lassetter JE, Bristow MR. OKT3 monoclonal antibody given for ten versus fourteen days as immunosuppressive prophylaxis in heart transplantation. J Heart Transplant. 1989 Jul-Aug; 8(4):303-9; discussion 309-10.
    View in: PubMed
    Score: 0.052
  11. O'Connell JB, Renlund DG, Gay WA, DeWitt CW, Hammond EH, Yowell RL, Jones KW, Karwande SV, Doty DB, Bristow MR. Efficacy of OKT3 retreatment for refractory cardiac allograft rejection. Transplantation. 1989 May; 47(5):788-92.
    View in: PubMed
    Score: 0.051
  12. Renlund DG, O'Connell JB, Bristow MR. Early rejection prophylaxis in heart transplantation: is cytolytic therapy necessary? J Heart Transplant. 1989 May-Jun; 8(3):191-3.
    View in: PubMed
    Score: 0.051
  13. O'Connell JB, Renlund DG, Bristow MR. Cardiac transplantation: emerging role of the internist/cardiologist. J Intern Med. 1989 Mar; 225(3):147-56.
    View in: PubMed
    Score: 0.051
  14. Gilbert EM, Eiswirth CC, Mealey PC, Larrabee P, Herrick CM, Bristow MR. Beta-adrenergic supersensitivity of the transplanted human heart is presynaptic in origin. Circulation. 1989 Feb; 79(2):344-9.
    View in: PubMed
    Score: 0.050
  15. Bristow MR, Lee HE, Gilbert EM, Renlund DG, Hegewald MG, Hershberger RE, O'Connell JB. Use of enoximone in patients awaiting cardiac transplant. Br J Clin Pract Suppl. 1988 Dec; 64:69-72.
    View in: PubMed
    Score: 0.050
  16. Gay WA, O'Connell JG, Burton NA, Karwande SV, Renlund DG, Bristow MR. OKT3 monoclonal antibody in cardiac transplantation. Experience with 102 patients. Ann Surg. 1988 Sep; 208(3):287-90.
    View in: PubMed
    Score: 0.049
  17. Gilbert EM, Krueger SK, Murray JL, Renlund DG, O'Connell JB, Gay WA, Bristow MR. Echocardiographic evaluation of potential cardiac transplant donors. J Thorac Cardiovasc Surg. 1988 Jun; 95(6):1003-7.
    View in: PubMed
    Score: 0.048
  18. Watson FS, O'Connell JB, Amber IJ, Renlund DG, Classen D, Johnston JM, Smith CB, Bristow MR. Treatment of cytomegalovirus pneumonia in heart transplant recipients with 9(1,3-dihydroxy-2-proproxymethyl)-guanine (DHPG). J Heart Transplant. 1988 Mar-Apr; 7(2):102-5.
    View in: PubMed
    Score: 0.047
  19. Bristow MR, Gilbert EM, O'Connell JB, Renlund DG, Watson FS, Hammond E, Lee RG, Menlove R. OKT3 monoclonal antibody in heart transplantation. Am J Kidney Dis. 1988 Feb; 11(2):135-40.
    View in: PubMed
    Score: 0.047
  20. Gilbert EM, Renlund DG, O'Connell JB, Eiswirth CC, Rothstein G, Gay WA, Bristow MR. Immunosuppressive efficacy of vincristine in heart transplantation: a preliminary report. J Heart Transplant. 1987 Nov-Dec; 6(6):369-74.
    View in: PubMed
    Score: 0.046
  21. Renlund DG, Gilbert EM, O'Connell JB, Gay WA, Jones KW, Burton NA, Doty DB, Karwande SV, Dewitt CW, Menlove RL, Herrick CM, Bristow MR. Age-associated decline in cardiac allograft rejection. Am J Med. 1987 09; 83(3):391-8.
    View in: PubMed
    Score: 0.046
  22. Gilbert EM, Eiswirth CC, Renlund DG, Menlove RL, DeWitt CW, Freedman LA, Herrick CM, Gay WA, Bristow MR. Use of Orthoclone OKT3 monoclonal antibody in cardiac transplantation: early experience with rejection prophylaxis and treatment of refractory rejection. Transplant Proc. 1987 Apr; 19(2 Suppl 1):45-53.
    View in: PubMed
    Score: 0.044
  23. Renlund DG, O'Connell JB, Gilbert EM, Watson FS, Bristow MR. Feasibility of discontinuation of corticosteroid maintenance therapy in heart transplantation. J Heart Transplant. 1987 Mar-Apr; 6(2):71-8.
    View in: PubMed
    Score: 0.044
  24. Gilbert EM, Dewitt CW, Eiswirth CC, Renlund DG, Menlove RL, Freedman LA, Herrick CM, Gay WA, Bristow MR. Treatment of refractory cardiac allograft rejection with OKT3 monoclonal antibody. Am J Med. 1987 Feb; 82(2):202-6.
    View in: PubMed
    Score: 0.044
  25. Taylor DO, Bristow MR, O'Connell JB, Price GD, Hammond EH, Doty DB, Karwande SV, Gay WA, Jones KW, Lapp? D, Renlund DG. Improved long-term survival after heart transplantation predicted by successful early withdrawal from maintenance corticosteroid therapy. J Heart Lung Transplant. 1996 Oct; 15(10):1039-46.
    View in: PubMed
    Score: 0.021
  26. Wagoner LE, Taylor DO, Olsen SL, Bristow MR, O'Connell JB, Hammond EH, Lappe DL, Renlund DG. Cyclophosphamide in cardiac transplant recipients with frequent rejection: a six-year retrospective review. Clin Transplant. 1996 Oct; 10(5):437-43.
    View in: PubMed
    Score: 0.021
  27. Ma H, Hammond EH, Taylor DO, Yowell RL, Bristow MR, O'Connell JB, Renlund DG. The repetitive histologic pattern of vascular cardiac allograft rejection. Increased incidence associated with longer exposure to prophylactic murine monoclonal anti-CD3 antibody (OKT3). Transplantation. 1996 Jul 27; 62(2):205-10.
    View in: PubMed
    Score: 0.021
  28. Renlund DG, Taylor DO, Ensley RD, O'Connell JB, Gilbert EM, Bristow MR, Ma H, Yanowitz FG. Exercise capacity after heart transplantation: influence of donor and recipient characteristics. J Heart Lung Transplant. 1996 Jan; 15(1 Pt 1):16-24.
    View in: PubMed
    Score: 0.020
  29. Costanzo MR, Augustine S, Bourge R, Bristow M, O'Connell JB, Driscoll D, Rose E. Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation. 1995 Dec 15; 92(12):3593-612.
    View in: PubMed
    Score: 0.020
  30. Hunt SA, Bristow MR, Kubo SH, O'Connell JB, Young JB. Guidelines for training in adult cardiovascular medicine. Core Cardiology Training Symposium (COCATS). Task Force 8: training in heart failure and transplantation. J Am Coll Cardiol. 1995 Jan; 25(1):29-31.
    View in: PubMed
    Score: 0.019
  31. Taylor DO, Bristow MR, O'Connell JB, Ensley RD, Olsen SL, Hammond EH, Wagoner LE, Renlund DG. A prospective, randomized comparison of cyclophosphamide and azathioprine for early rejection prophylaxis after cardiac transplantation. Decreased sensitization to OKT3. Transplantation. 1994 Sep 27; 58(6):645-9.
    View in: PubMed
    Score: 0.019
  32. Bristow MR, Minobe WA, Raynolds MV, Port JD, Rasmussen R, Ray PE, Feldman AM. Reduced beta 1 receptor messenger RNA abundance in the failing human heart. J Clin Invest. 1993 Dec; 92(6):2737-45.
    View in: PubMed
    Score: 0.018
  33. Wagoner LE, Olsen SL, Bristow MR, O'Connell JB, Taylor DO, Lappe DL, Renlund DG. Cyclophosphamide as an alternative to azathioprine in cardiac transplant recipients with suspected azathioprine-induced hepatotoxicity. Transplantation. 1993 Dec; 56(6):1415-8.
    View in: PubMed
    Score: 0.018
  34. Ensley RD, Bristow MR, Olsen SL, Taylor DO, Hammond EH, O'Connell JB, Dunn D, Osburn L, Jones KW, Kauffman RS, et al. The use of mycophenolate mofetil (RS-61443) in human heart transplant recipients. Transplantation. 1993 Jul; 56(1):75-82.
    View in: PubMed
    Score: 0.017
  35. Baldwin JC, Anderson JL, Boucek MM, Bristow MR, Jennings B, Ritsch ME, Silverman NA. 24th Bethesda conference: Cardiac transplantation. Task Force 2: Donor guidelines. J Am Coll Cardiol. 1993 Jul; 22(1):15-20.
    View in: PubMed
    Score: 0.017
  36. Olsen SL, Wagoner LE, Hammond EH, Taylor DO, Yowell RL, Ensley RD, Bristow MR, O'Connell JB, Renlund DG. Vascular rejection in heart transplantation: clinical correlation, treatment options, and future considerations. J Heart Lung Transplant. 1993 Mar-Apr; 12(2):S135-42.
    View in: PubMed
    Score: 0.017
  37. Ratkovec RM, Hammond EH, O'Connell JB, Bristow MR, DeWitt CW, Richenbacher WE, Millar RC, Renlund DG. Outcome of cardiac transplant recipients with a positive donor-specific crossmatch--preliminary results with plasmapheresis. Transplantation. 1992 Oct; 54(4):651-5.
    View in: PubMed
    Score: 0.016
  38. Merigan TC, Renlund DG, Keay S, Bristow MR, Starnes V, O'Connell JB, Resta S, Dunn D, Gamberg P, Ratkovec RM, et al. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N Engl J Med. 1992 Apr 30; 326(18):1182-6.
    View in: PubMed
    Score: 0.016
  39. Price GD, Olsen SL, Taylor DO, O'Connell JB, Bristow MR, Renlund DG. Corticosteroid-free maintenance immunosuppression after heart transplantation: feasibility and beneficial effects. J Heart Lung Transplant. 1992 Mar-Apr; 11(2 Pt 2):403-14.
    View in: PubMed
    Score: 0.016
  40. Marks JD, Karwande SV, Richenbacher WE, Jones KW, Doty DB, Millar RC, O'Connell JB, Renlund DG, Bristow MR, Pantalos GM, et al. Perioperative mechanical circulatory support for transplantation. J Heart Lung Transplant. 1992 Jan-Feb; 11(1 Pt 1):117-28.
    View in: PubMed
    Score: 0.015
  41. Richenbacher WE, Karwande SV, Shaddy RE, Renlund DG, Bristow MR, O'Connell JB, Gay WA. Cardiac transplantation in a patient with a single ventricle and transposition of the great vessels. Ann Thorac Surg. 1991 Oct; 52(4):871-3.
    View in: PubMed
    Score: 0.015
  42. Hammond EH, Ensley RD, Yowell RL, Craven CM, Bristow MR, Renlund DG, O'Connell JB. Vascular rejection of human cardiac allografts and the role of humoral immunity in chronic allograft rejection. Transplant Proc. 1991 Apr; 23(2 Suppl 2):26-30.
    View in: PubMed
    Score: 0.015
  43. Moore CK, O'Connell JB, Renlund DG, Bristow MR, Hammond EH. Cardiac allograft cellular rejection during OKT3 prophylaxis in the absence of sensitization. Transplant Proc. 1991 Feb; 23(1 Pt 2):1055-8.
    View in: PubMed
    Score: 0.014
  44. O'Connell JB, Bristow MR, Hammond EH, Menlove RL, Ensley RD, Ratkovec RM, Renlund DG. Antimurine antibody to OKT3 in cardiac transplantation: implications for prophylaxis and retreatment of rejection. Transplant Proc. 1991 Feb; 23(1 Pt 2):1157-9.
    View in: PubMed
    Score: 0.014
  45. Ensley RD, Hammond EH, Renlund DG, Yowell RL, Bristow MR, DeWitt CW, Menlove RL, Ratkovec RM, O'Connell JB. Clinical manifestations of vascular rejection in cardiac transplantation. Transplant Proc. 1991 Feb; 23(1 Pt 2):1130-2.
    View in: PubMed
    Score: 0.014
  46. O'Connell JB, Renlund DG, Bristow MR, Hammond EH. Detection of allograft endothelial cells of recipient origin following ABO-compatible, nonidentical cardiac transplantation. Transplantation. 1991 Feb; 51(2):438-42.
    View in: PubMed
    Score: 0.014
  47. O'Connell JB, Bristow MR, Rasmussen LG, Ratkovec RM, Gay WA, Jones KW, Renlund DG. Cardiac allograft function with corticosteroid-free maintenance immunosuppression. Circulation. 1990 Nov; 82(5 Suppl):IV318-21.
    View in: PubMed
    Score: 0.014
  48. Hammond EH, Wittwer CT, Greenwood J, Knape WA, Yowell RL, Menlove RL, Craven C, Renlund DG, Bristow MR, DeWitt CW, et al. Relationship of OKT3 sensitization and vascular rejection in cardiac transplant patients receiving OKT3 rejection prophylaxis. Transplantation. 1990 Nov; 50(5):776-82.
    View in: PubMed
    Score: 0.014
  49. Olsen SL, O'Connell JB, Bristow MR, Renlund DG. Methotrexate as an adjunct in the treatment of persistent mild cardiac allograft rejection. Transplantation. 1990 Nov; 50(5):773-5.
    View in: PubMed
    Score: 0.014
  50. Ratkovec RM, Wray RB, Renlund DG, O'Connell JB, Bristow MR, Gay WA, Karwande SV, Doty DB, Millar RC, Menlove RL, et al. Influence of corticosteroid-free maintenance immunosuppression on allograft coronary artery disease after cardiac transplantation. J Thorac Cardiovasc Surg. 1990 Jul; 100(1):6-12.
    View in: PubMed
    Score: 0.014
  51. Moore CK, Bristow MR, Renlund DG, Rasmussen LG, O'Connell JB. Long-term morbidity of cyclosporine with corticosteroid-free maintenance immunosuppression in cardiac transplantation. Transplant Proc. 1990 Jun; 22(3 Suppl 1):25-9.
    View in: PubMed
    Score: 0.014
  52. Hammond EH, Watson FS, Bristow MR, O'Connell JB, Gilbert EM, Doty DB, Renlund DG. Fibrinoid necrosis of a temporal artery complicating the treatment of refractory cardiac allograft rejection with murine monoclonal CD3 antibody (OKT3). J Heart Transplant. 1990 May-Jun; 9(3 Pt 1):236-8.
    View in: PubMed
    Score: 0.014
  53. Hammond EH, Yowell RL, Nunoda S, Menlove RL, Renlund DG, Bristow MR, Gay WA, Jones KW, O'Connell JB. Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant. 1989 Nov-Dec; 8(6):430-43.
    View in: PubMed
    Score: 0.013
  54. Wittwer CT, Knape WA, Bristow MR, Gilbert EM, Renlund DG, O'Connell JB, DeWitt CW. The quantitative flow cytometric plasma OKT3 assay. Its potential application in cardiac transplantation. Transplantation. 1989 Sep; 48(3):533-5.
    View in: PubMed
    Score: 0.013
  55. Renlund DG, Bristow MR, Crandall BG, Burton NA, Doty DB, Karwande SV, Gay WA, Jones KW, Hegewald MG, Hagan ME, et al. Hypercholesterolemia after heart transplantation: amelioration by corticosteroid-free maintenance immunosuppression. J Heart Transplant. 1989 May-Jun; 8(3):214-9; discussion 219-20.
    View in: PubMed
    Score: 0.013
  56. Renlund DG, Bristow MR, O'Connell JB. Cardiac transplantation--the need for prospective, randomized, controlled investigations. West J Med. 1988 Nov; 149(5):583-5.
    View in: PubMed
    Score: 0.012
  57. Renlund DG, Bristow MR, Lee HR, O'Connell JB. Medical aspects of cardiac transplantation. J Cardiothorac Anesth. 1988 Aug; 2(4):500-12.
    View in: PubMed
    Score: 0.012
  58. Yowell RL, Hammond EH, Bristow MR, Watson FS, Renlund DG, O'Connell JB. Acute vascular rejection involving the major coronary arteries of a cardiac allograft. J Heart Transplant. 1988 May-Jun; 7(3):191-7.
    View in: PubMed
    Score: 0.012
  59. Wittwer CT, Bristow MR, Gilbert EM, Renlund DG, O'Connell JB, DeWitt CW. OKT3 therapy as a cause of high panel-reactive antibodies in serum using standard microcytotoxicity techniques. Transplantation. 1988 Apr; 45(4):832-4.
    View in: PubMed
    Score: 0.012
  60. Renlund DG, Bristow MR, Burton NA, Jones KW, Karwande SV, Gay WA. Survival following cardiac transplantation--what are acceptable standards? West J Med. 1987 May; 146(5):627-30.
    View in: PubMed
    Score: 0.011
  61. Renlund DG, Bristow MR, Lybbert MR, O'Connell JB, Gay WA. Medicare-designated centers for cardiac transplantation. N Engl J Med. 1987 Apr 02; 316(14):873-6.
    View in: PubMed
    Score: 0.011
  62. Domanski M, Krause-Steinrauf H, Deedwania P, Follmann D, Ghali JK, Gilbert E, Haffner S, Katz R, Lindenfeld J, Lowes BD, Martin W, McGrew F, Bristow MR. The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial. J Am Coll Cardiol. 2003 Sep 03; 42(5):914-22.
    View in: PubMed
    Score: 0.009
  63. Lurie KG, Bristow MR, Reitz BA. Increased beta-adrenergic receptor density in an experimental model of cardiac transplantation. J Thorac Cardiovasc Surg. 1983 Aug; 86(2):195-201.
    View in: PubMed
    Score: 0.009
  64. Lurie KG, Billingham ME, Masek MA, Ginsburg R, Bristow MR, Harrison D, Reitz BA. Ultrastructural and functional studies on prolonged myocardial preservation in an experimental heart transplant model. J Thorac Cardiovasc Surg. 1982 Jul; 84(1):122-9.
    View in: PubMed
    Score: 0.008
  65. Eichhorn EJ, Domanski MJ, Krause-Steinrauf H, Bristow MR, Lavori PW. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med. 2001 05 31; 344(22):1659-67.
    View in: PubMed
    Score: 0.007
  66. Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson A. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet. 1993 Dec 11; 342(8885):1441-6.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)